Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther Ads (NQ: ADAP )

4.840 USD +0.060 (+1.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adaptimmune Ther Ads

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Adaptimmune's HiT Program Can Potentially Kill Human Tumor Cells, Animal Study Shows
Adaptimmune Therapeutics plc(NASDAQ:ADAP) hasreported first preclinical datafrom its HiT targeting mesothelin ... 
Tags General News tumors
From Benzinga
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model
From GlobeNewswire News Releases
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DCPH FLGT CLBS
From Benzinga
Adaptimmune Reports First Quarter Financial Results and Business Update
From GlobeNewswire News Releases
Earnings Outlook for Adaptimmune Therapeutics
On Thursday, May 06, Adaptimmune Therapeutics (NASDAQ:ADAP) will release its latest earnings report. Benzinga's report can help you ... 
Tags Earnings BZI/EP Benzinga
From Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA ... 
Tags MRNA AXNX PLX
From Benzinga
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
From GlobeNewswire News Releases
Adaptimmune to Report Q1 2021 Financial Results and Business Update on Thursday, May 6, 2021
From GlobeNewswire News Releases
The Implied Analyst 12-Month Target For MOON
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of ADAP May 21st Options Trading
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options begin trading this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADAP... 
Tags Stocks
From Market News Video
Thinking about buying stock in Oramed Pharmaceuticals, Mogo, Chiasma, Adaptimmune Therapeutics, or Dynatronics?
InvestorsObserver issues critical PriceWatch Alerts for ORMP, MOGO, CHMA, ADAP, and DYNT. 
From PR Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Savara (NASDAQ:SVRA) stock increased by 16.75% to $2.09 during Wednesday's after-market session. Trading volume for this ... 
Tags KDMN OPGN Health Care
From Benzinga
Analysts Predict 11% Upside For The Holdings of MOON
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GKOS VIR HZNP
From Benzinga
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
From GlobeNewswire News Releases
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags NVRO TNDM GBT
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NARI Penny Stocks AEZS
From Benzinga
17 Stocks Moving In Tuesday's After-Hours Session
Gainers SolarEdge (NASDAQ: SEDG) shares are trading higher after the company reported better-than-expected Q4 EPS and sales ... 
Tags KAR EDRY Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 16.53% to $2.89 during Tuesday's after-market session. This security ... 
Tags Health Care OTLK AHPI
From Benzinga
Adaptimmune to Report Fourth Quarter/ Full Year 2020 Financial Results and Business Updates on Thursday, February 25, 2021
From GlobeNewswire News Releases
Bullish Two Hundred Day Moving Average Cross - ADAP
In trading on Monday, shares of Adaptimmune Therapeutics PLC (ADAP) crossed above their 200 day moving average of $6.98, changing hands as high as $7.28 per share. Adaptimmune Therapeutics PLC shares... 
Tags Stocks
From Market News Video
First Week of ADAP February 19th Options Trading
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the February 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down... 
Tags Stocks
From Market News Video
5 Best Penny Stocks To Buy Now According To Insiders
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
First Week of January 2021 Options Trading For Adaptimmune Therapeutics (ADAP)
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day
From GlobeNewswire News Releases
Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS
From GlobeNewswire News Releases
Adaptimmune to Host Virtual Investor Day on Friday, November 20th
From GlobeNewswire News Releases
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
From GlobeNewswire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ALT SUPN ALPN
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ALNY ADAP VCEL
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.